Z85.29, Personal history of malignant neoplasm of other respiratory and intrathoracic organsICD-10-CM
No Prior Auth Required
Covered without prior authorization (high confidence)
CGS-J15-L38822, MolDX: Minimal Residual Disease Testing for Cancer
J15
CGS-J18-L38822, MolDX: Minimal Residual Disease Testing for Cancer
J18
A58756, Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J5
WPS-J5-L38835, MolDX: Minimal Residual Disease Testing for Cancer
J5
WPS-J5-L39040, MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J5
A58468, Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
J5
NGS-J6-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6
A52450, Billing and Coding: Paclitaxel (e.g., Taxol/Abraxane )
J6
WPS-J8-L39040, MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
J8
WPS-J8-L38835, MolDX: Minimal Residual Disease Testing for Cancer
J8
NGS-JK-L33394, Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
JK
AETNA-CPB-0071, Positron Emission Tomography (PET)
A58679, Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A54768, Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
A56580, Billing and Coding: Computerized Axial Tomography (CT), Thorax
A57204, Billing and Coding: MRI and CT Scans of the Head and Neck
A58376, Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
A58434, Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
A58454, Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
ANTHEM-MP-A050278, Last Review Date
Ask Backwork about documentation requirements, denial risks, or coverage in your state.